Top brokers name 3 ASX shares to buy next week

Brokers gave the thumbs up to these ASX shares last week. Why are they bullish?

| More on:
A man in trendy clothing sits on a bench in a shopping mall looking at his phone with interest and a surprised look on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This led to the release of a large number of broker notes.

Three ASX broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

AGL Energy Limited (ASX: AGL)

According to a note out of UBS, its analysts have retained their buy rating on this energy giant's shares with a slightly reduced price target of $11.25. UBS was pleased with AGL's first half result, noting that it was well ahead of the broker's expectations. It sees potential for further earnings outperformance in the coming years if its generation availability can be maintained. The AGL share price ended the week at $8.63.

CSL Ltd (ASX: CSL)

A note out of Morgans reveals that its analysts have retained their add rating on this biotechnology giant's shares with a trimmed price target of $315.40. This follows the release of a solid half-year result which revealed earnings ahead of consensus expectations. Overall, Morgans was pleased with the result and especially the performance of the key CSL Behring business. And although the broker has trimmed its valuation to reflect the CSL112 trial failure, it continues to see a lot of value on offer. The CSL share price was trading at $284.00 at Friday's close.

Pro Medicus Limited (ASX: PME)

Analysts at Macquarie have retained their outperform rating and $120.00 price target on this health imaging technology company's shares. Macquarie notes that Pro Medicus fell short of the broker's first-half expectations with both its revenue and earnings. However, it remains positive given new contract wins and its healthy sales pipeline. The Pro Medicus share price was trading at $87.24 on Friday.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Morgans names more of the best ASX shares to buy

The broker has given these shares a big thumbs up.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

These ASX 300 shares could rise 20% to 65%

Big returns could be on the cards for these shares according to analysts.

Read more »

Miner and company person analysing results of a mining company.
Resources Shares

Buy one, sell the other: Goldman's verdict on these 2 ASX 200 mining shares

The broker sees significant valuation differences between these 2 major ASX 200 mining shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Morgans says these are some of the very best ASX 200 shares to buy

The broker believes these shares could be destined to deliver big returns.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Broker Notes

Where to invest $8,000 on the ASX in April 2024

A leading broker thinks these shares would be quality options this month.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Happy couple doing grocery shopping together.
Broker Notes

Buy one, sell the other: Goldman's verdict on Coles vs. Woolworths share prices

One stock is set for a 26% share price gain over the next 12 months while the other is destined…

Read more »